Long-acting anti-diabetic peptide drug based on genetic fusion with an albumin-binding aptide

被引：0
|
作者：
Kim, S. [1 ]
机构：
[1] Korea Inst Ceram Engn & Technol, Cheongjusi, South Korea
来源：
NEW BIOTECHNOLOGY | 2018年 / 44卷
关键词：
D O I：
10.1016/j.nbt.2018.05.1118
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
P27-12
引用
收藏
页码：S143 / S144
页数：2
相关论文
共 23 条
  • [1] An approach for half-life extension and activity preservation of an anti-diabetic peptide drug based on genetic fusion with an albumin-binding aptide
    Kim, Daejin
    Jeon, Hyungsu
    Ahn, Sukyung
    Choi, Won Il
    Kim, Sunghyun
    Jon, Sangyong
    [J]. JOURNAL OF CONTROLLED RELEASE, 2017, 256 : 114 - 120
  • [2] FATTY-ACID ACYLATED INSULINS ARE LONG-ACTING DUE TO ALBUMIN-BINDING
    KURTZHALS, P
    HAVELUND, S
    JONASSEN, I
    RIBEL, U
    MARKUSSEN, J
    [J]. DIABETOLOGIA, 1995, 38 : A191 - A191
  • [3] Albumin-Binding Evans Blue Derivatives for Diagnostic Imaging and Production of Long-Acting Therapeutics
    Jacobson, Orit
    Kiesewetter, Dale O.
    Chen, Xiaoyuan
    [J]. BIOCONJUGATE CHEMISTRY, 2016, 27 (10) : 2239 - 2247
  • [4] Improving pharmacological activities of thrombopoietin mimetic peptide by genetic fusion to albumin-binding domain
    Dezhou Li
    Guosheng Gao
    Bo Zhu
    Jingjing Ying
    [J]. Biotechnology Letters, 2023, 45 : 439 - 448
  • [5] Improving pharmacological activities of thrombopoietin mimetic peptide by genetic fusion to albumin-binding domain
    Li, Dezhou
    Gao, Guosheng
    Zhu, Bo
    Ying, Jingjing
    [J]. BIOTECHNOLOGY LETTERS, 2023, 45 (04) : 439 - 448
  • [6] Purification and characterization of a long-acting ciliary neurotrophic factor via genetically fused with an albumin-binding domain
    Xu, Longfu
    Zhang, Chun
    Liu, Liping
    Zhang, Yao
    Wang, Qi
    Wang, Jian
    Liu, Yongdong
    Su, Zhiguo
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 2017, 139 : 14 - 20
  • [7] Development of a long acting FGF21 analogue-albumin fusion protein and its anti-diabetic effects
    Watanabe, Hiroshi
    Miyahisa, Masako
    Chikamatsu, Mayuko
    Nishida, Kento
    Minayoshi, Yuki
    Takano, Mei
    Ichimizu, Shota
    Kobashigawa, Yoshihiro
    Morioka, Hiroshi
    Maeda, Hitoshi
    Maruyama, Toru
    [J]. JOURNAL OF CONTROLLED RELEASE, 2020, 324 : 522 - 531
  • [8] Exploring a novel long-acting glucagon-like peptide-1 receptor agonist built on the albumin-binding domain and XTEN scaffolds
    Zhou, Yan
    Li, Jianhui
    Gao, Guosheng
    Li, Yafeng
    Zhang, Changzhen
    [J]. HELIYON, 2024, 10 (02)
  • [9] Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities
    Graham, Galyna, V
    Conlon, J. Michael
    Abdel-Wahab, Yasser H.
    Flatt, Peter R.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 878
  • [10] Phenylbutazone, a New Long-Acting Agent that can Improve the Peptide Pharmacokinetic Based on Serum Albumin as a Drug Carrier
    Zhou, Jie
    Li, Xue
    Zhu, Xiaoyun
    Sun, Jian
    Qiu, Qianqian
    Huang, Wenlong
    Qian, Hai
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2016, 87 (06) : 936 - 945
123